Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT04141553

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Mercy Health Muskegon (from the registry)
Registry
  • NCT NCT04141553
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04141553. Randomized; single masking; primary purpose treatment. Start 2019-12-01 (anticipated); primary completion 2021-12-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter
Condition
Rapid Ventricular Response
Intervention (Drug)
Diltiazem Injection
Lead sponsor
Mercy Health Muskegon (class: other)

Record details

Record id
cardio:ct-nct04141553
Content hash
2aafac6fc05d1379324df2aa827ae11f40661e6fa7840ae6a03144fd8216e1b2